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Gastrinomas: a difficult tumour to diagnose and treat
Gastrinomas are rare neuroendocrine tumours that can occur sporadically or in association with MEN 
1 syndrome. For most HPB surgeons they represent an interesting but rare reprieve from treating pan-
creatic adenocarcinoma given their favourable outcomes. Just how rare they are is demonstrated in this 
issue of HPB by Atema et al. A 20 year retrospective review from a large tertiary centre managed to find 
only eleven patients who underwent potentially curable surgery. Despite this small number of patients, 
a number of important issues can be identified. It was notable that the median time to diagnosis was 8 
years, highlighting the need to be vigilant for symptoms other than those related to complicated ulcer 
disease. Five of the 11 patients complained of persistent diarrhoea. The level of serum gastrin was 600 ng/l 
or less in five of the 11 patients. All patients had tumours that were identified on cross sectional imaging 
although in one patient the primary tumour was not found at subsequent surgery. The surgery was 
tailored to the individual patient and ranged from enucleation or central pancreatectomy through to 
pancreaticoduodenectomy. However it should be kept in mind that gastrinomas frequently (50–70%) 
metastasize to draining lymph nodes but whether upfront radical surgery can offer survival benefit could 
not be determined from this study. Given the rarity and complexity of these tumours the authors conclude 
these patients are best managed through a multidisciplinary pathway to optimise the diagnosis, investiga-
tion, treatment and follow up.
Saxon Connor
Closing the book on open cholecystectomy in cirrhosis
Offer most surgeons the opportunity to take out the gall bladder in a patient with cirrhosis and they will 
run a mile. The perceived wisdom for many years was that if you were forced to perform a cholecystec-
tomy in a cirrhotic patient this would be better done as an open procedure as the potential for rapid 
control of bleeding was much better. The trouble was that no single centre had enough cases to test this 
anecdotal opinion. Chmielecki and colleagues in this month’s edition of HPB have undertaken a popula-
tion based study to address the question of whether it is better to undertake a laparoscopic or an open 
cholecystectomy in a patient with cirrhosis. Using Nationwide Inpatient Sample data they identified over 
3000 patients with cirrhosis who had undergone cholecystectomy. Twelve percent of these patients had 
open cholecystectomy with the majority having an attempt at laparoscopic cholecystectomy. Conversion 
rates to open surgery were high with 14% converted, but outcomes were much better in those patients 
undergoing laparoscopic surgery. Specifically, transfusion requirements, postoperative liver failure and 
infection rates were all lower in laparoscopically treated patients. The stand out result, however, was a 6 
fold lower operative mortality in laparoscopic (1.3%) versus open cholecystectomy patients (8.3%). The 
dataset does not allow analysis of severity of liver disease which would have allowed greater confidence 
in excluding selection bias. The message seems fairly clear, however, if your patient has cirrhosis and they 
need a cholecystectomy – unless there are compelling reasons otherwise, this should be attempted 
laparoscopically.
Stephen J Wigmore
Preventing pancreatic fistula: we need an App for that
Isn’t it amazing in 2012 that no consensus has been reached as to the best way to close the pancreatic 
remnant after a distal pancreatectomy (DP)? Today, a rover cruises Mars, the internet and mobile devices 
unite the world but we still cannot reliably prevent post-operative pancreatic fistula (POPF) after a rela-
tively common operation. Beyond our ISGPF classification, agreed-upon risk factors and new predictive 
models, we thankfully have committed surgeons driven to solve this troublesome and uncompromising 
complication. Among them are Klein et al. from Berlin who summarize outcomes in 47 DP patients who 
had a pancreatoenteral (PE) anastomosis (jejunum or stomach) to the transected pancreatic remnant 
instead of precise direct closure (DC) alone (n = 151). The incidence of POPF was higher following DC 
(22% vs. 11% PE), however more patients bled post-operatively after PE (11% vs. 7% DC). Ultimately, 
no significant differences in mortality or overall morbidity were seen regardless of what surgical approach 
was taken. The authors duly note the limitations of their retrospective study that evaluated a limited 
sample size. Nonetheless, they show as others have that PE is a safe, reliable and likely equivalent option 
for preventing POPF in selected patients. It requires technical prowess, however, and may be impractical 
for laparoscopic or robotic-assisted DP. Until a technical solution is achieved, we must rely on individual 
risk-stratification and meticulous peri-operative care. We do have an App for that.
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